Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study.

"CONFLICTS OF INTEREST Robert J. de Knegt consults for and received grants from AbbVie. He is on the speakers’ bureau for Echosens. He received grants from Gilead and Janssen. DISCLOSURES M.J.S. has received speaker's fees and research support from Fujirebio and received grants from Gilead. R.dK. is a speaker for Echosens, a consultant for AbbVie, and received grants from AbbVie, Gilead, and Janssen. Other authors had no conflict of interest."

"FUNDING INFORMATION The Rotterdam Study is funded by the Erasmus Medical Center and Erasmus University (Rotterdam, The Netherlands); the Organization for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. Financial support was also provided by the Foundation for Liver and Gastrointestinal Research (Rotterdam, The Netherlands). The funding sources did not influence study design, data collection, analysis and interpretation of the data, nor the writing of the report and decision to submit for publication. Funding information Erasmus Medisch Centrum; Erasmus Universiteit Rotterdam; European Commission; Ministerie van Onderwijs, Cultuur en Wetenschap; Ministerie van Volksgezondheid, Welzijn en Sport; Research institute for diseases in the elderly; Stichting voor Lever-en Maag-Darm Onderzoek; ZonMw"

"The Rotterdam Study has been approved by the Medical Ethics Committee of Erasmus MC (registration no.: MEC 02.1015) and by the Dutch Ministry of Health, Welfare and Sport (Population Screening Act WBO; license no.: 1071272‐159521‐PG). The Rotterdam Study Personal Registration Data collection is filed with the Erasmus MC Data Protection Officer under registration number EMC1712001. The Rotterdam Study has been entered into the Netherlands National Trial Register (NTR; www.trialregister.nl) and into the World Health Organization International Clinical Trials Registry Platform (ICTRP; www.who.int/ictrp/network/primary/en/) under shared catalog number NTR6831. All participants provided written informed consent to participate in the study and have their information obtained from treating physicians. All authors had access to the study data and reviewed and approved the final manuscript. Participants were not involved in the research design and conduct."